Letrozole 2.5 mg tablet
Letrozole 2.5 mg tablet
How it works
Letrozole is a nonsteroidal competitive inhibitor of the aromatase enzyme system; it inhibits the conversion of androgens to estrogens. In adult nontumor- and tumor-bearing female animals, letrozole is as effective as ovariectomy in reducing uterine weight, elevating serum LH, and causing the regression of estrogen-dependent tumors. In contrast to ovariectomy, treatment with letrozole does not lead to an increase in serum FSH. Letrozole selectively inhibits gonadal steroidogenesis but has no significant effect on adrenal mineralocorticoid or glucocorticoid synthesis.
Letrozole inhibits the aromatase enzyme by competitively binding to the heme of the cytochrome P450 subunit of the enzyme, resulting in a reduction of estrogen biosynthesis in all tissues. Treatment of women with letrozole significantly lowers serum estrone, estradiol and estrone sulfate and has not been shown to significantly affect adrenal corticosteroid synthesis, aldosterone synthesis, or synthesis of thyroid hormones.
The growth of some cancers of the breast is stimulated or maintained by estrogens. Treatment of breast cancer thought to be hormonally responsive (i.e., estrogen and/or progesterone receptor positive or receptor unknown) has included a variety of efforts to decrease estrogen levels (ovariectomy, adrenalectomy, hypophysectomy) or inhibit estrogen effects Page 2 (antiestrogens and progestational agents). These interventions lead to decreased tumor mass or delayed progression of tumor growth in some women.
In postmenopausal women, estrogens are mainly derived from the action of the aromatase enzyme, which converts adrenal androgens (primarily androstenedione and testosterone) to estrone and estradiol. The suppression of estrogen biosynthesis in peripheral tissues and in the cancer tissue itself can therefore be achieved by specifically inhibiting the aromatase enzyme.
Infertility to assist ovulation
2.5 mg from day 3 of cycle (for 5 days) ———— max till 3 cycles
Adjuvant with other medication in females with breast cancer
2.5 mg OD can go till 5 years
Stomach or abdominal upset, Diarrhea
Biliary cirrhosis, hepatic disease, Osteoporosis, Hypercholesterolemia, Children, Pregnancy, Breast-feeding
(Clindamycin 100mg+Clotrimazole 100 mg+Metronidazole 100 mg + Lactobacillus 150mn spores Tablet)
Ferrous Bisglycinate (eq. to Elemental Iron) 60 mg +Zinc Bisglycinate (eq. to Elemental Zinc) 15 mg +Folic Acid 1 mg + Mecobalamin 500 mg tablet